Drugs / ALK Alutard SQ Betula verrucosa
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04912076 Comparator | Sep 2018 → Mar 2019 | allergic disease | Odense University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALK Alutard SQ Betula verrucosa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04912076 ↗ |
| Route | Subcutaneous | “Subcutaneous injections with increasing doses of Alutard according to cluster up-dosing scheme” NCT04912076 ↗ |